MONTREAL, May 09, 2024 (GLOBE NEWSWIRE) — Knight Therapeutics Inc. (TSX: GUD) (“Knight” or “the Company”), a leading pan-American (ex-US) specialty pharmaceutical company, today reported financial results for its first quarter ended
2024 Highlights Read More
Related
Share this page
Guest Posts by Easy Branches